Entero Therapeutics, Stock Price History

Stocks . USA . 
Stock . Entero Therapeutics,
ENTO Stock   0.47  0.01  2.17%   
Below is the normalized historical share price chart for Entero Therapeutics, extending back to October 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Entero Therapeutics, stands at 0.47, as last reported on the 29th of November, with the highest price reaching 0.49 and the lowest price hitting 0.43 during the day.
IPO Date
11th of October 2016
200 Day MA
3.1462
50 Day MA
0.5777
Beta
1.373
 
Covid
If you're considering investing in Entero Stock, it is important to understand the factors that can impact its price. Entero Therapeutics, appears to be risky, given 3 months investment horizon. Entero Therapeutics, secures Sharpe Ratio (or Efficiency) of 0.0632, which denotes the company had a 0.0632% return per unit of risk over the last 3 months. By reviewing Entero Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please utilize Entero Therapeutics,'s Downside Deviation of 8.64, coefficient of variation of 1783.25, and Mean Deviation of 7.0 to check if our risk estimates are consistent with your expectations.
  
At this time, Entero Therapeutics,'s Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Common Stock Shares Outstanding is likely to grow to about 353.2 K, while Other Stockholder Equity is likely to drop about 165.1 M. . As of the 29th of November 2024, Price Earnings Ratio is likely to drop to -0.09. In addition to that, Price Book Value Ratio is likely to drop to 0.34. Entero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0632

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsENTO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 12.52
  actual daily
96
96% of assets are less volatile

Expected Return

 0.79
  actual daily
15
85% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Entero Therapeutics, is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entero Therapeutics, by adding it to a well-diversified portfolio.
Price Book
0.0684
Book Value
7.991
Enterprise Value
66.3 M
Enterprise Value Ebitda
(0.10)
Shares Float
2.4 M

Entero Therapeutics, Stock Price History Chart

There are several ways to analyze Entero Stock price data. The simplest method is using a basic Entero candlestick price chart, which shows Entero Therapeutics, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 18, 20240.74
Lowest PriceSeptember 23, 20240.31

Entero Therapeutics, November 29, 2024 Stock Price Synopsis

Various analyses of Entero Therapeutics,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Entero Stock. It can be used to describe the percentage change in the price of Entero Therapeutics, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Entero Stock.
Entero Therapeutics, Price Daily Balance Of Power 0.17 
Entero Therapeutics, Accumulation Distribution 3,058 
Entero Therapeutics, Price Action Indicator 0.01 
Entero Therapeutics, Price Rate Of Daily Change 1.02 

Entero Therapeutics, November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Entero Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Entero Therapeutics, intraday prices and daily technical indicators to check the level of noise trading in Entero Stock and then apply it to test your longer-term investment strategies against Entero.

Entero Stock Price History Data

The price series of Entero Therapeutics, for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 0.43 with a coefficient of variation of 26.71. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.48. The median price for the last 90 days is 0.44. The company completed 1:20 stock split on 18th of December 2023.
OpenHighLowCloseVolume
11/29/2024 0.45  0.49  0.43  0.47  24,977 
11/29/2024
 0.45  0.48  0.41  0.46 
11/27/2024 0.45  0.48  0.41  0.46  21,200 
11/26/2024 0.48  0.48  0.45  0.47  58,800 
11/25/2024 0.45  0.49  0.45  0.47  37,500 
11/22/2024 0.42  0.46  0.39  0.45  50,100 
11/21/2024 0.40  0.42  0.39  0.42  27,400 
11/20/2024 0.41  0.43  0.38  0.40  85,600 
11/19/2024 0.43  0.44  0.38  0.41  95,700 
11/18/2024 0.49  0.49  0.42  0.44  149,100 
11/15/2024 0.50  0.50  0.44  0.49  65,561 
11/14/2024 0.62  0.62  0.43  0.52  586,600 
11/13/2024 0.56  0.68  0.56  0.63  1,832,658 
11/12/2024 0.64  0.65  0.61  0.62  45,973 
11/11/2024 0.68  0.68  0.60  0.64  50,800 
11/08/2024 0.66  0.72  0.66  0.69  19,000 
11/07/2024 0.70  0.70  0.66  0.66  39,621 
11/06/2024 0.68  0.71  0.65  0.68  25,675 
11/05/2024 0.65  0.72  0.65  0.71  29,700 
11/04/2024 0.68  0.72  0.63  0.67  93,000 
11/01/2024 0.65  0.72  0.65  0.69  115,000 
10/31/2024 0.61  0.65  0.61  0.64  48,341 
10/30/2024 0.60  0.61  0.58  0.61  39,084 
10/29/2024 0.60  0.62  0.53  0.60  224,703 
10/28/2024 0.63  0.69  0.57  0.58  255,800 
10/25/2024 0.68  0.72  0.63  0.63  105,800 
10/24/2024 0.63  0.75  0.62  0.68  294,600 
10/23/2024 0.62  0.63  0.58  0.61  59,400 
10/22/2024 0.65  0.65  0.59  0.62  254,200 
10/21/2024 0.76  0.77  0.66  0.68  261,433 
10/18/2024 0.76  0.87  0.66  0.74  571,100 
10/17/2024 0.54  0.73  0.54  0.73  1,240,700 
10/16/2024 0.47  0.64  0.45  0.56  1,188,218 
10/15/2024 0.48  0.49  0.45  0.45  121,600 
10/14/2024 0.47  0.48  0.42  0.46  148,000 
10/11/2024 0.42  0.51  0.41  0.47  366,000 
10/10/2024 0.43  0.45  0.39  0.40  134,800 
10/09/2024 0.42  0.47  0.38  0.42  296,913 
10/08/2024 0.52  0.58  0.40  0.42  1,125,000 
10/07/2024 0.53  0.72  0.50  0.52  2,044,397 
10/04/2024 0.38  0.75  0.36  0.60  9,514,308 
10/03/2024 0.34  0.37  0.34  0.35  25,100 
10/02/2024 0.34  0.34  0.32  0.33  47,400 
10/01/2024 0.34  0.35  0.32  0.32  39,708 
09/30/2024 0.35  0.35  0.33  0.34  38,100 
09/27/2024 0.35  0.35  0.34  0.34  26,600 
09/26/2024 0.33  0.35  0.33  0.35  30,000 
09/25/2024 0.32  0.35  0.32  0.33  35,000 
09/24/2024 0.31  0.33  0.31  0.32  62,900 
09/23/2024 0.34  0.36  0.31  0.31  50,000 
09/20/2024 0.37  0.37  0.33  0.33  52,392 
09/19/2024 0.36  0.37  0.34  0.34  92,826 
09/18/2024 0.37  0.38  0.34  0.34  42,747 
09/17/2024 0.34  0.38  0.34  0.35  33,700 
09/16/2024 0.37  0.39  0.31  0.37  116,600 
09/13/2024 0.35  0.39  0.33  0.35  231,900 
09/12/2024 0.44  0.45  0.28  0.33  265,201 
09/11/2024 0.44  0.45  0.42  0.44  93,776 
09/10/2024 0.42  0.46  0.40  0.41  1,106,400 
09/09/2024 0.40  0.42  0.40  0.40  30,404 
09/06/2024 0.39  0.40  0.36  0.40  49,600 

About Entero Therapeutics, Stock history

Entero Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entero Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entero Therapeutics, stock prices may prove useful in developing a viable investing in Entero Therapeutics,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding336.3 K353.2 K

Entero Therapeutics, Stock Technical Analysis

Entero Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of Entero Therapeutics, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entero Therapeutics, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Entero Therapeutics, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entero Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Entero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance0.0523
Jensen Alpha0.2791
Total Risk Alpha(1.17)
Sortino Ratio0.065
Treynor Ratio0.1962
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
When determining whether Entero Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entero Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entero Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entero Therapeutics, Stock:
How To Invest In Entero
Details
Is Entero Stock a good investment?
Details
What is Entero Therapeutics,'s Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entero Therapeutics,. If investors know Entero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entero Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.04)
Return On Assets
(0.27)
Return On Equity
(0.15)
The market value of Entero Therapeutics, is measured differently than its book value, which is the value of Entero that is recorded on the company's balance sheet. Investors also form their own opinion of Entero Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Entero Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entero Therapeutics,'s market value can be influenced by many factors that don't directly affect Entero Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Entero Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Entero Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entero Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY